Mitsubishi UFJ Asset Management Co. Ltd. Invests $3.17 Million in National Health Investors, Inc. $NHI

Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in National Health Investors, Inc. (NYSE:NHI) during the second quarter, HoldingsChannel reports. The firm acquired 41,592 shares of the real estate investment trust’s stock, valued at approximately $3,172,000.

Several other large investors have also modified their holdings of the stock. International Assets Investment Management LLC acquired a new stake in National Health Investors in the fourth quarter valued at about $27,000. EverSource Wealth Advisors LLC grew its holdings in National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in National Health Investors during the 4th quarter valued at about $33,000. Advisory Services Network LLC purchased a new position in shares of National Health Investors during the 3rd quarter worth approximately $65,000. Finally, Triumph Capital Management acquired a new position in shares of National Health Investors in the third quarter worth $66,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Price Performance

Shares of NYSE:NHI opened at $73.59 on Friday. The company has a market cap of $3.61 billion, a PE ratio of 21.27, a P/E/G ratio of 3.39 and a beta of 0.51. National Health Investors, Inc. has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81. The firm has a 50-day simple moving average of $75.48 and a 200 day simple moving average of $79.10.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The business had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, sell-side analysts anticipate that National Health Investors, Inc. will post 4.77 EPS for the current year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors’s dividend payout ratio is 106.36%.

Insider Buying and Selling at National Health Investors

In other news, Director Robert A. Mccabe, Jr. bought 890 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were purchased at an average price of $71.65 per share, with a total value of $63,768.50. Following the completion of the acquisition, the director directly owned 44,159 shares in the company, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was purchased at an average price of $68.84 per share, with a total value of $103,260.00. Following the acquisition, the chief executive officer owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 2.70% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on NHI shares. Deutsche Bank Aktiengesellschaft cut their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a report on Thursday, June 25th. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. BMO Capital Markets decreased their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research report on Monday, June 15th. Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Finally, Wells Fargo & Company lowered their price objective on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $83.86.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.